Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer

BACKGROUND: Retrospective analyses suggest that capecitabine may carry superior activity in hormone receptor‐positive relative to hormone receptor‐negative metastatic breast cancer. This review examined the veracity of that finding and explored whether this differential activity extends to early bre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Hoon, Siao-Nge, Lau, Peter K H, White, Alison M, Bulsara, Max K, Banks, Patricia D, Redfern, Andrew D
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2021
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8150746/
https://ncbi.nlm.nih.gov/pubmed/34037241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011220.pub2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados